1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Investigación quirúrgica en urología y trasplante renal

Investigación quirúrgica en urología y trasplante renal

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Artiles Medina A, Tagalos Muñoz A, Domínguez Gutiérrez A, Muriel García A, Subiela JD, Álvarez Díaz N, Fernández Conejo G, Gómez Dos Santos V, Coloma Del Peso A, Burgos Revilla FJ.

    Outcomes of Active Treatment for Localised Prostate Cancer After Holmium Laser Enucleation of the Prostate: A Systematic Review and Meta-analysis

    European Urology Open Science . 79: 111-127.

    [doi:10.1016/j.euros.2025.07.011]

  • Massari F, Mollica V, Kopp RM, Grande E, Fiala O, Kanesvaran R, Li H, Schieber TJ, Juan Fita MJ, Poprach A, Lolli C, Bourlon MT, de Liaño AG, Grillone F, Sunela K, Rizzo A, Ghosn M, Cerbone L, Taha T, Ürün Y, Molina-Cerrillo J, Alonso-Gordoa T, Lenci E, Martin IO, Abu-Sini H, Rescigno P, Bhuva D, Fay AP, Conteduca V, Yildirim A, Rosellini M, Akova U, Tassinari E, Bölek H, Soares A, Marques Monteiro FS, Buti S, Bilen MA, Santoni M.

    Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study

    European Urology Focus . 11(5): 736-746.

    [doi:10.1016/j.euf.2025.05.020]

  • Krajewski W, Nowak L, Laszkiewicz J, Chorbinska J, Tomczak W, Gurwin A, Moschini M, Pradere B, Gallioli A, Subiela JD, Laukhtina E, Del Giudice F, Marcq G, Afferi L, Krajewska M, Khan MS, Nair R, Malkiewicz B, Szydelko T.

    Impact of Histological Subtypes/Divergent Differentiation on Clinicopathological and Oncological Outcomes for Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Comprehensive Updated Systematic Review and Meta-analysis

    European Urology Oncology . 8(4): 1126-1139.

    [doi:10.1016/j.euo.2025.03.003]

  • Subiela JD, Guerrero-Ramos F, Rodríguez-Faba Ó, Aumatell J, Gajate P, López-Campos F, Sevillano E, Hernández-Arroyo M, García-Rojo E, Artiles Medina A, Sáenz-Calzada D, Gómez-Cañizo C, Romero-Otero J, Couñago F.

    New insights and emerging approaches in bladder-sparing treatment for muscle-invasive bladder cancer.

    Actas Urologicas Espanolas . 49(7): 501758-501758.

    [doi:10.1016/j.acuroe.2025.501758]

  • Artiles Medina A, Bajawi Carretero M, López Pérez E, Garach Fernández S, López Curtis D, Elías Pascual L, Subiela JD, Soto Pérez-Olivares J, Nieto Góngora C, González Tello F, de la Parra Sánchez I, Mínguez Ojeda C, Gómez Dos Santos V, Burgos Revilla FJ.

    Impact of Preoperative CT-Diagnosed Sarcopenic Obesity on Outcomes After Radical Cystectomy for Bladder Cancer.

    Cancers . 17(16): .

    [doi:10.3390/cancers17162669]

  • Fernández-Conejo G, Subiela Henríquez JD, Tagalos Muñoz A, González Álvarez C, Fernández Mardomingo A, Sanz Mayayo E, Díez Nicolás V, García Barreras S, Gómez Dos Santos V, Rodríguez-Patrón R, Burgos Revilla FJ.

    Standardizing radical prostatectomy with the Versius robotic system: technical setup and early institutional experience

    Journal of Robotic Surgery . 19(1): 470-470.

    [doi:10.1007/s11701-025-02639-0]

  • Lopez-Valcarcel M, Lopez-Campos F, Zafra-Martín J, Cienfuegos Belmonte I, Subiela JD, Ruiz-Vico M, Fernandez Alonso S, Garcia Cuesta JA, Couñago F.

    Biomarkers in Localized Prostate Cancer: From Diagnosis to Treatment

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 26(16): . Nº de citas: 1

    [doi:10.3390/ijms26167667]

  • Jimenez-Fonseca P, Álvarez-Escola C, Ballester Navarro I, Hernando Cubero J, González Fernández L, Mangas Cruz MÁ, Iglesias C, García-Donas J, Picón MJ, Paja M, González Batanero L, García L, Molina J, Jimeno Maté R, Aller J, Romero MDCT, Cardenas Salas J, Gutiérrez-Buey G, Egaña Zunzunegui N, Navarro M, Lecumberri MJ, Valdés N, Carmona-Bayonas A.

    External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy

    EUROPEAN JOURNAL OF ENDOCRINOLOGY . 193(2): 320-328.

    [doi:10.1093/ejendo/lvaf171]

  • Subiela JD, de la Parra I, Taborda J, Medina AA, Pichler R, Krajewski W, Ojeda CM, Mardomingo AF, Durán PDO, Pérez EL, González-Padilla DA, Aumatell J, Mori K, Scilipoti P, Longoni M, de Angelis M, Caño-Velasco J, Puentedura AL, Pujol LP, Contieri R, Gallioli A, Tukiendorf A, D'Andrea D, Teoh JY, Afferi L, Del Giudice F, Marcq G, Albisinni S, Soria F, Mertens LS, Laukhtina E, Tully K, Mari A, Guerrero-Ramos F, Alvarez-Maestro M, Martín CC, Melendres FA, Buisan O, López-González JA, Dominguez-Escrig JL, Aranda J, Elena JLR, Basile G, Santos VGD, Moschini M, Pradere B, Acosta EA, Palacio FL, Puig AC, Gajate P, Saiz A, Gontero P, Revilla FJB.

    Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapy

    BJU INTERNATIONAL . : .

    [doi:10.1111/bju.16913]

  • Fernandes C, Viegas V, Saavedra M, Casado J, Sánchez A, Velasco C, Cabañes L, Luque C, Artiles A, San José L, Lopez-Fando Lavalle L.

    Advancing the diagnosis and management of pudendal nerve entrapment: The role of neurophysiological studies and imaging-guided infiltrations

    Neuroradiology . 67(8): 2239-2245. Nº de citas: 2

    [doi:10.1007/s00234-025-03645-7]

  • Araujo-Castro M, Mínguez Ojeda C, Gómez Dos Santos V, Sanjuanbenito A, Gómez Ramírez J, Mercander E, Hanzu F, Zarain L, Vidal Ó, Muriel García A, Artiles Medina A.

    Surgical outcomes of partial adrenalectomy for pheochromocytoma: A systematic review and meta-analysis

    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS . 26(4): 625-640. Nº de citas: 2

    [doi:10.1007/s11154-025-09962-9]

  • Fernandes C, Viegas V, Artiles Medina A, Martins Silva C, San José L, López-Fando Lavalle L.

    Male pudendal nerve release assisted by laparoscopy and intraoperative neurophysiologic monitoring.

    Neurocirugia . : 500714-500714.

    [doi:10.1016/j.neucie.2025.500714]

  • Pichler R, van Creij NCH, Mertens LS, Del Giudice F, Koll F, Soria F, Subiela JD, Plage H, Tymoszuk P, Mayr R, Klinglmair G, Seeber A, Pichler M, Günther M, Ormanns S, Compérat E, Li R, Moschini M, Pradére B.

    FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial Carcinoma.

    European Urology Oncology . : .

    [doi:10.1016/j.euo.2025.07.005]

  • Bourlon MT, Galli L, Grande E, Park SH, Melichar B, Schieber TJ, Juan-Fita MJ, Ürün Y, Molina-Cerrillo J, Alonso-Gordoa T, De Giorgi U, Kucharz J, Pérez Calabuig E, Conteduca V, Taha T, Rescigno P, Abu-Sini H, Spinelli GP, Manneh Kopp R, Salfi A, Bhuva D, Valdez-Sandoval P, Mendez-Bribiesca S, Fiala O, Buti S, Marques Monteiro FS, Bamias A, Ghosn M, Massari F, Ansari J, Santoni M.

    Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study

    Frontiers in Oncology . 15: 1605282-1605282. Nº de citas: 1

    [doi:10.3389/fonc.2025.1605282]

  • Manneh R, Molina-Cerrillo J, de Velasco G, Ibatá L, Martínez S, Ruiz-Granados Á, Alonso-Gordoa T.

    PARP Inhibitors for Metastatic CRPC: More Answers than Questions, a Systematic Review and Meta-Analysis

    PHARMACEUTICALS . 18(7): .

    [doi:10.3390/ph18071015]

  • Fernández O, Molina A, Anido-Herranz U, Alvarez C, Gironés R, Gajate P, Domínguez RG, Ros S, Puente J, Blasco S, Oré-Arce M, Martinez EN, Fernández-Freire A, Del Pozo N, Cassinello J, Lázaro-Quintela M, Arranz F, Crespo G, Abad MT, Llorente M, Sánchez-Hernández A, Juan MJ.

    Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-025-03978-y]

  • López Curtis DA, Artiles Medina A, Subiela JD, Fernández-Mardomingo Díaz A, González Tello F, Muriel García A, de la Parra Sánchez I, Mínguez Ojeda C, Jiménez Cidre MÁ, Gómez Dos Santos V, Burgos Revilla FJ.

    Revisiting angiomyolipomas: The significance of a rich blood supply on imaging for risk-adapted decision making

    Investigative and Clinical Urology . 66(4): 285-294.

    [doi:10.4111/icu.20250059]

  • Rizzo M, Soares A, Gupta S, Calabrò F, Takeshita H, Bourlon MT, Park SH, Giannatempo P, Myint ZW, Büttner T, Grande E, Fiala O, Santini D, Bamias A, Zakopoulou R, Buti S, Kanesvaran R, Rescigno P, Molina-Cerrillo J, Epstein I, Marques Monteiro FS, Massari F, Porta C, Bellmunt J, Santoni M.

    Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study

    Jco Global Oncology . 11: .

    [doi:10.1200/GO-24-00564]